Plain-English translation of NCT07564752 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →The HAGI-T1D study is investigating how better blood sugar control affects a specific type of cholesterol called HDL (the 'good' cholesterol) in people with type 1 diabetes. Researchers will work with patients to improve their diabetes management through adjusted insulin therapy, education, and lifestyle changes, then monitor how this improvement affects HDL. The study will compare these changes to a group of healthy people without diabetes to see if good blood sugar control can restore HDL to normal levels.
People with type 1 diabetes often have problems with their cholesterol that increase their risk of heart disease, even when their blood sugar is controlled. This study wants to understand whether improving blood sugar control can fix these cholesterol problems and reduce that heart disease risk.
You likely qualify if…
You likely don't qualify if…
If you have poorly controlled type 1 diabetes, you will be hospitalized briefly in the diabetes department at Dijon University Hospital to receive intensive therapy management, including adjustments to your insulin regimen, education about diabetes care, and guidance on diet and lifestyle changes. Throughout the study, you will have blood samples taken to measure your cholesterol and blood sugar levels, allowing researchers to see how your improved diabetes control affects your HDL cholesterol composition and function. The study lasts approximately three months, during which you'll work with the diabetes care team to achieve better blood sugar control.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France